For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 342 mcg | IBI-10090: dexamethasone | None | None | 6 | 58 | 2 | 58 | View |
| 517 mcg | IBI-10090: dexamethasone | None | None | 2 | 56 | 2 | 56 | View |
| 697 mcg | IBI-10090: dexamethasone | None | None | 3 | 58 | 1 | 58 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Cervix carcinoma | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Corneal edema | None | Eye disorders | None | View |
| Corneal endothelial cell loss | None | Eye disorders | None | View |
| Endophthalmitis | None | Eye disorders | None | View |
| Influenza | None | Respiratory, thoracic and mediastinal disorders | None | View |